Rajamäki, Finland

Jari Helin

This inventor holds 13 USPTO granted patents and 18 published patent applications, plus 3 CIPO patents and 12 EPO patents, primarily in Glycoprotein Conjugates. Top assignees: Glykos Finland Oy, Nutrileads B.v., Tenboron Oy. Active years: 2012-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jari Helin. Retrieved from https://idiyas.com/inventor/jari-helin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 76.9

 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Vantaa, FI (2012)
  • Helsinki, FI (2016 - 2019)
  • Rajamaki, FI (2016 - 2021)
  • Rajamäki, FI (2013 - 2023)

Company Filing History:


Years Active: 2012-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Hydrophilic Linkers
Toxic Payload
Glycoprotein Conjugates
Polysaccharide
Immune Modulation
Saccharide Derivatives
Antibody Conjugates
Cancer Oligosaccharides
Isolation Methods
Yeast Hydrolysis
Glycan Conjugates
Compounds Combinations
13 patents (USPTO):Explore Patents

Title: Innovations of Jari Helin

Introduction

Jari Helin is a notable inventor based in Rajamaki, Finland. He has made significant contributions to the field of biotechnology, holding a total of 13 patents. His work primarily focuses on the development of innovative solutions in the realm of glycoproteins and their applications in pharmaceuticals.

Latest Patents

Among his latest patents, Jari Helin has developed hydrophilic linkers and their conjugates. These inventions include a glycoprotein-toxic payload molecule conjugate and a toxic payload molecule-glycan conjugate. His work also encompasses pharmaceutical compositions and methods for preparing these conjugates, as well as techniques for modulating the growth of cell populations and treating tumor cells.

Career Highlights

Throughout his career, Jari Helin has worked with various companies, including Glykos Finland Oy and Nutrileads B.V. His expertise in biotechnology has allowed him to contribute to advancements in drug development and therapeutic applications.

Collaborations

Jari has collaborated with notable professionals in his field, including Tero Satomaa and Juhani Saarinen. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Jari Helin's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the industry. His work continues to influence advancements in pharmaceutical applications and therapeutic methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…